Person:

Brenner, Michael

Loading...
Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Brenner

First Name

Michael

Name

Brenner, Michael

Search Results

Now showing 1 - 6 of 6
  • Publication

    The synovial cadherin (cadherin-11) promotes intercellular motility

    (BioMed Central, 2007) Kiener, Hans P; Stipp, Christopher S; Allen, Philip G; Lee, David Marvin; Brenner, Michael
  • Publication

    Cadherin-11 regulates synovial fibroblast behavior in health and disease

    (BioMed Central, 2007) Lee, David Marvin; Kiener, Hans P; Agarwal, Sandeep K; Noss, Erika H; Watts, Gerald; Chisaka, Osamu; Takeichi, Masatoshi; Brenner, Michael
  • Publication

    Synthesis and Biological Activity of α-Galactosyl Ceramide KRN7000 and Galactosyl (α1→2) Galactosyl Ceramide

    (Elsevier Science Ltd, 2009) Veerapen, Natacha; Brigl, Manfred; Garg, Salil; Cerundolo, Vincenzo; Cox, Liam R.; Brenner, Michael; Besra, Gurdyal S.

    We herein report a faster and less cumbersome synthesis of the biologically attractive, α-galactosyl ceramide (α-GalCer), known as KRN7000, and its analogues. More importantly, the use of a silicon tethered intramolecular glycosylation reaction gave easy access to the diglycosyl ceramide Gal(α1→2)GalCer, which has been shown to require uptake and processing to the biologically active α-GalCer derivative.

  • Publication

    CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice

    (Rockefeller University Press, 2009) Felio, Kyrie; Nguyen, Hanh; Dascher, Christopher C.; Choi, Hak-Jong; Li, Sha; Zimmer, Michael I.; Colmone, Angela; Moody, David; Brenner, Michael; Wang, Chyung-Ru

    Group 1 CD1 (CD1a, CD1b, and CD1c)–restricted T cells recognize mycobacterial lipid antigens and are found at higher frequencies in Mycobacterium tuberculosis (Mtb)–infected individuals. However, their role and dynamics during infection remain unknown because of the lack of a suitable small animal model. We have generated human group 1 CD1 transgenic (hCD1Tg) mice that express all three human group 1 CD1 isoforms and support the development of group 1 CD1–restricted T cells with diverse T cell receptor usage. Both mycobacterial infection and immunization with Mtb lipids elicit group 1 CD1–restricted Mtb lipid–specific T cell responses in hCD1Tg mice. In contrast to CD1d-restricted NKT cells, which rapidly respond to initial stimulation but exhibit anergy upon reexposure, group 1 CD1–restricted T cells exhibit delayed primary responses and more rapid secondary responses, similar to conventional T cells. Collectively, our data demonstrate that group 1 CD1–restricted T cells participate in adaptive immune responses upon mycobacterial infection and could serve as targets for the development of novel Mtb vaccines.

  • Publication

    CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids

    (The Rockefeller University Press, 2009) Van Rhijn, Ildiko; De Jong, Annemieke; Vazquez, Jenny; Cheng, Tan-Yun; Barral, Duarte C.; León, Luis; Riese, Richard; Costello, Catherine E.; Porcelli, Steven A.; Briken, Volker; Young, David Stephenson; Young, David C.; Talekar, Rahul Subhash; Brenner, Michael; Katz, Joel; Ruprecht, Ruth Margrit; O'Connor, Peter B.; Moody, David

    The recent discovery of dideoxymycobactin (DDM) as a ligand for CD1a demonstrates how a nonribosomal lipopeptide antigen is presented to T cells. DDM contains an unusual acylation motif and a peptide sequence present only in mycobacteria, but its discovery raises the possibility that ribosomally produced viral or mammalian proteins that commonly undergo lipidation might also function as antigens. To test this, we measured T cell responses to synthetic acylpeptides that mimic lipoproteins produced by cells and viruses. CD1c presented an N-acyl glycine dodecamer peptide (lipo-12) to human T cells, and the response was specific for the acyl linkage as well as the peptide length and sequence. Thus, CD1c represents the second member of the CD1 family to present lipopeptides. lipo-12 was efficiently recognized when presented by intact cells, and unlike DDM, it was inactivated by proteases and augmented by protease inhibitors. Although lysosomes often promote antigen presentation by CD1, rerouting CD1c to lysosomes by mutating CD1 tail sequences caused reduction in lipo-12 presentation. Thus, although certain antigens require antigen processing in lysosomes, others are destroyed there, providing a hypothesis for the evolutionary conservation of large CD1 families containing isoforms that survey early endosomal pathways.

  • Publication

    CD1c Bypasses Lysosomes to Present a Lipopeptide Antigen with 12 Amino Acids

    (The Rockefeller University Press, 2009) De Jong, Annemieke; Vazquez, Jenny; Cheng, Tan-Yun; Barral, Duarte C.; León, Luis; Riese, Richard; Costello, Catherine E.; Porcelli, Steven A.; Briken, Volker; Van Rhijn, Ildiko; Young, David C.; Talekar, Rahul Subhash; Brenner, Michael; Katz, Joel; Ruprecht, Ruth Margrit; O'Connor, Peter B.; Moody, David

    The recent discovery of dideoxymycobactin (DDM) as a ligand for CD1a demonstrates how a nonribosomal lipopeptide antigen is presented to T cells. DDM contains an unusual acylation motif and a peptide sequence present only in mycobacteria, but its discovery raises the possibility that ribosomally produced viral or mammalian proteins that commonly undergo lipidation might also function as antigens. To test this, we measured T cell responses to synthetic acylpeptides that mimic lipoproteins produced by cells and viruses. CD1c presented an N-acyl glycine dodecamer peptide (lipo-12) to human T cells, and the response was specific for the acyl linkage as well as the peptide length and sequence. Thus, CD1c represents the second member of the CD1 family to present lipopeptides. lipo-12 was efficiently recognized when presented by intact cells, and unlike DDM, it was inactivated by proteases and augmented by protease inhibitors. Although lysosomes often promote antigen presentation by CD1, rerouting CD1c to lysosomes by mutating CD1 tail sequences caused reduction in lipo-12 presentation. Thus, although certain antigens require antigen processing in lysosomes, others are destroyed there, providing a hypothesis for the evolutionary conservation of large CD1 families containing isoforms that survey early endosomal pathways.